Surgery Partners (SGRY) Liabilities and Shareholders Equity (2014 - 2026)

Surgery Partners has disclosed Liabilities and Shareholders Equity across 13 years of filings, most recently posting $8.0 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $8.0 billion, up 1.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.1 billion (up 3.89% YoY), and the FY2025 annual result was $8.1 billion, up 2.91% from the prior year.
• Liabilities and Shareholders Equity came in at $8.0 billion for Q1 2026 at Surgery Partners, down from $8.1 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $8.1 billion in Q4 2025 to a low of $6.3 billion in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $7.0 billion (2024), against an average of $7.2 billion.
• Across the five-year window, Liabilities and Shareholders Equity grew 16.07% in 2022 and climbed 1.17% in 2026, its largest moves.
• Surgery Partners' Liabilities and Shareholders Equity stood at $6.7 billion in 2022, then gained by 2.91% to $6.9 billion in 2023, then grew by 14.74% to $7.9 billion in 2024, then grew by 2.91% to $8.1 billion in 2025, then decreased by 0.96% to $8.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $8.0 billion (Q1 2026), $8.1 billion (Q4 2025), and $7.9 billion (Q3 2025), per Business Quant data.